|
|
| Quarterly Results |
|
| Cipla Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Y K Hamied | | Home : Indian Private | Book Value: 320.5640364 | | BSE Code : 500087 | Market Cap: 115033.6 | | NSE Code : CIPLA | P / E : 34.98 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 3798.31 | 3736.46 | 3857.73 | 3485.68 | | Other Income | 265.36 | 319.24 | 157.98 | 119.71 | | Total Income | 4646.69 | 4553.68 | 4476.17 | 4013.45 | | Total Expenditure | 3025.47 | 3009.06 | 3113.50 | 3279.86 | | Operating Profit | 1621.22 | 1544.62 | 1362.67 | 733.59 | | Interest | 9.06 | 6.61 | 0.31 | 10.46 | | Gross Profit | 1612.16 | 1538.01 | 1362.36 | 723.13 | | Depreciation | 135.02 | 179.81 | 135.95 | 161.58 | | Tax | 348.69 | 329.81 | 340.34 | 244.64 | | Deferred Tax | 14.31 | -1.30 | -8.95 | -38.58 | | Reported Profit After Tax | 1114.14 | 1029.69 | 895.02 | 355.49 |
|
|
|
|
|